Fezolinetant
Fezolinetant
Fezolinetant (pronounced feh-zoh-lih-net-ant) is a non-peptide, orally active, selective neurokinin 3 receptor (NK3R) antagonist. It is currently under development for the treatment of vasomotor symptoms (VMS) associated with menopause.
Etymology
The term "Fezolinetant" is a coined name for this specific drug, and does not have a known etymology.
Pharmacology
Fezolinetant works by blocking the neurokinin 3 receptor (NK3R), a receptor found in the brain that is involved in the regulation of body temperature. By blocking this receptor, Fezolinetant can help to reduce the frequency and severity of hot flashes associated with menopause.
Clinical Trials
Fezolinetant is currently in Phase III clinical trials for the treatment of vasomotor symptoms associated with menopause. Early results from these trials have shown that Fezolinetant is effective in reducing the frequency and severity of hot flashes in postmenopausal women.
Related Terms
External links
- Medical encyclopedia article on Fezolinetant
- Wikipedia's article - Fezolinetant
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski